BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9062485)

  • 21. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia.
    Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Wong W; Chan DC
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2429-32. PubMed ID: 9253312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants.
    Ng PC; Lam CW; Lee CH; Chan IH; Wong SP; Fok TF
    Neonatology; 2008; 94(3):170-5. PubMed ID: 18612214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone.
    Allolio B; Schulte HM; Deuss U; Kallabis D; Hamel E; Winkelman W
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):509-14. PubMed ID: 3033966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal hydrocortisone therapy does not have a serious suppressive effect on the later function of the hypothalamus-pituitary-adrenal axis.
    Takayanagi T; Matsuo K; Egashira T; Mizukami T
    Acta Paediatr; 2015 May; 104(5):e195-9. PubMed ID: 25605127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency.
    Maguire AM; Biesheuvel CJ; Ambler GR; Moore B; McLean M; Cowell CT
    Clin Endocrinol (Oxf); 2008 May; 68(5):683-91. PubMed ID: 18070143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early pituitary-adrenal responses and retinopathy of prematurity in very low birth weight infants.
    Ng PC; Kwok AK; Lee CH; Tam BS; Lam CW; Ma KC; Chan IH; Wong E; Lam DS; Fok TF
    Pediatr Res; 2004 Jan; 55(1):114-9. PubMed ID: 14605253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenocorticotropin and cortisol responses to vasopressin during pregnancy.
    Goland RS; Wardlaw SL; MacCarter G; Warren WB; Stark RI
    J Clin Endocrinol Metab; 1991 Aug; 73(2):257-61. PubMed ID: 1649836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man.
    Watabe T; Tanaka K; Kumagae M; Itoh S; Kogure M; Hasegawa M; Horiuchi T; Morio K; Takeda F; Ubukata E
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1132-7. PubMed ID: 2836468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
    Grottoli S; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; DeStefanis S; Camanni F; Ghigo E; Arvat E
    J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
    Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
    Moreira AC; Elias LL
    J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants.
    Ng PC; Lee CH; Lam CW; Ma KC; Fok TF; Chan IH; Wong E
    Arch Dis Child Fetal Neonatal Ed; 2004 Mar; 89(2):F119-26. PubMed ID: 14977894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.
    Kamilaris TC; DeBold CR; Pavlou SN; Island DP; Hoursanidis A; Orth DN
    J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.